30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kelly, Jared Ryan

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kelly, Jared Ryan's trades of Oncolytics Biotech Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-12
B Purchase
87,692 -19.5%
39.78
US$4,001,854 		87,692 -19.5% 39.78 US$4,001,854
2026-02-13 2026-02-12
B Purchase
55,208 -40.3%
17.34
US$4,894,943 		55,208 -40.3% 17.34 US$4,894,943
2026-02-13 2026-02-11
B Purchase
94,540 +31.3%
259.26
US$1,011,155 		94,540 +31.3% 259.26 US$1,011,155
2025-08-12 2025-08-12
B Purchase
23,500 +46.6%
0.86
US$20,280 		23,500 +46.6% 0.86 US$20,280
2025-07-17 2025-07-16
B Purchase
50,400
1.19
US$60,062 		50,400 1.19 US$60,062